The global pharmaceutical industry relies heavily on a robust and dependable supply chain for its raw materials and intermediates. Among these, specialized chemical compounds known as pharmaceutical intermediates are crucial for the synthesis of active pharmaceutical ingredients (APIs). One such vital intermediate is [(2S)-1-ethylpyrrolidin-2-yl]methanamine, identified by its CAS number 22795-99-9. Its significance lies primarily in its role as a precursor for drugs like Levonsulpiride, necessitating stringent quality control and consistent availability.

When sourcing an intermediate like [(2S)-1-ethylpyrrolidin-2-yl]methanamine, several key attributes must be prioritized. Firstly, purity is paramount. Impurities can affect reaction yields, complicate purification processes, and, most importantly, compromise the safety and efficacy of the final drug. Secondly, for chiral intermediates, the enantiomeric purity or specific optical activity is critical. The biological activity of many drugs is stereospecific, meaning only one enantiomer provides the desired therapeutic effect, while the other might be inactive or even detrimental. CAS 22795-99-9 is valued for its specific (S) configuration.

The global market for these intermediates is vast, with many leading manufacturers located in China. Companies like NINGBO INNO PHARMCHEM CO., LTD. are prominent suppliers, offering high-quality materials at competitive prices. For businesses looking to buy CAS 22795-99-9, engaging with these suppliers often involves requesting detailed technical data sheets, certificates of analysis (CoA), and potentially free samples for validation. This due diligence ensures that the sourced material meets the exact specifications required for pharmaceutical production, especially for complex syntheses like that of Levonsulpiride.

Establishing a reliable sourcing strategy for pharmaceutical intermediates is a cornerstone of successful drug manufacturing. It involves not only identifying reputable suppliers but also understanding the chemical properties and regulatory requirements associated with each compound. The consistent supply of high-purity, enantiomerically specific intermediates like [(2S)-1-ethylpyrrolidin-2-yl]methanamine is fundamental to maintaining production schedules, ensuring product quality, and ultimately delivering essential medications to patients worldwide.